Literature DB >> 19546161

Dual role of Ski in pancreatic cancer cells: tumor-promoting versus metastasis-suppressive function.

Peng Wang1, Zhen Chen, Zhi-Qiang Meng, Jie Fan, Jian-Min Luo, Wang Liang, Jun-Hua Lin, Zhen-Hua Zhou, Hao Chen, Kun Wang, Ye-Hua Shen, Zu-De Xu, Lu-Ming Liu.   

Abstract

Ski used to be defined as an oncogene that contributes to the resistance of tumor cells to transforming growth factor-beta (TGF-beta)-induced growth arrest. As TGF-beta has a dual effect on tumor growth with both tumor-suppressing and -promoting activity depending on the stage of carcinogenesis and the cell type, the precise role of Ski in carcinogenesis remains unclear. In this study, we show that downregulation of Ski through lentivirus-mediated RNA interference decreases tumor growth both in vitro and in vivo, yet promotes cell invasiveness in vitro, and lung metastasis in vivo in the pancreatic cancer cell line SW1990, which contain wild-type Smad4 expression, and the BxPC3 cell line, which is Smad4 deficient. We also show that the downregulation of Ski increases TGF-beta-induced transcriptional activity, which is associated with increased TGF-beta-dependent Smad2/3 phosphorylation, and results in an altered expression profile of TGF-beta-inducible genes involved in metastasis, angiogenesis and cell proliferation and epithelial-mesenchymal transition. Immunohistochemical analysis of specimens from 71 patients with pancreatic adenocarcinoma showed a significant association between overexpression of Ski and decreased patient survival time (P = 0.0024). Our results suggest that Ski may act as a tumor proliferation-promoting factor or as a metastatic suppressor in human pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19546161     DOI: 10.1093/carcin/bgp154

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  22 in total

1.  JDP2 inhibits the epithelial-to-mesenchymal transition in pancreatic cancer BxPC3 cells.

Authors:  Zhe Liu; Ruixia Du; Jin Long; Anbing Dong; Jianpeng Fan; Kejian Guo; Yuanhong Xu
Journal:  Tumour Biol       Date:  2012-04-27

2.  Identification of Ski as a target for Aurora A kinase.

Authors:  Jocelyn Mosquera; Ricardo Armisen; Hongling Zhao; Diego A Rojas; Edio Maldonado; Julio C Tapia; Alicia Colombo; Michael J Hayman; Katherine Marcelain
Journal:  Biochem Biophys Res Commun       Date:  2011-05-12       Impact factor: 3.575

3.  Ski modulate the characteristics of pancreatic cancer stem cells via regulating sonic hedgehog signaling pathway.

Authors:  Libin Song; Xiangyuan Chen; Song Gao; Chenyue Zhang; Chao Qu; Peng Wang; Luming Liu
Journal:  Tumour Biol       Date:  2016-10-12

Review 4.  Neoadjuvant therapy for pancreas cancer: past lessons and future therapies.

Authors:  Jeffrey M Sutton; Daniel E Abbott
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

5.  MED29, a component of the mediator complex, possesses both oncogenic and tumor suppressive characteristics in pancreatic cancer.

Authors:  Riina Kuuselo; Kimmo Savinainen; Saana Sandström; Reija Autio; Anne Kallioniemi
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

6.  Suppression of p53 activity through the cooperative action of Ski and histone deacetylase SIRT1.

Authors:  Yasumichi Inoue; Shun-ichiro Iemura; Tohru Natsume; Keiji Miyazawa; Takeshi Imamura
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

7.  SKI promotes Smad3 linker phosphorylations associated with the tumor-promoting trait of TGFbeta.

Authors:  Qiushi Lin; Dahu Chen; Nikolai A Timchenko; Estela E Medrano
Journal:  Cell Cycle       Date:  2010-05-21       Impact factor: 4.534

8.  SKI knockdown suppresses apoptosis and extracellular matrix degradation of nucleus pulposus cells via inhibition of the Wnt/β-catenin pathway and ameliorates disc degeneration.

Authors:  Zuo-Long Wu; Ya-Jun Chen; Guang-Zhi Zhang; Qi-Qi Xie; Ke-Ping Wang; Xin Yang; Tai-Cong Liu; Zhi-Qiang Wang; Guang-Hai Zhao; Hai-Hong Zhang
Journal:  Apoptosis       Date:  2022-02-11       Impact factor: 4.677

9.  Next generation sequencing analysis of miRNAs: MiR-127-3p inhibits glioblastoma proliferation and activates TGF-β signaling by targeting SKI.

Authors:  Huawei Jiang; Chengmeng Jin; Jie Liu; Dasong Hua; Fan Zhou; Xiaoyan Lou; Na Zhao; Qing Lan; Qiang Huang; Jae-Geun Yoon; Shu Zheng; Biaoyang Lin
Journal:  OMICS       Date:  2014-02-11

10.  The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL.

Authors:  Peng Wang; Liping Zhuang; Juan Zhang; Jie Fan; Jianmin Luo; Hao Chen; Kun Wang; Luming Liu; Zhen Chen; Zhiqiang Meng
Journal:  Mol Oncol       Date:  2012-11-07       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.